≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Pyoderma gangrenosum

DOID EFO MESH PheWeb

L12_PYODERMAGANGRENOSUM

pyoderma gangrenosum: ['An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.']

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 L88
Hospital discharge: ICD-9 $!$
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 L88
Cause of death: ICD-9 $!$
Cause of death: ICD-8 $!$

134

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

134

diagram downward connector

Check minimum number of events None

134

diagram downward connector

Include endpoints None

134

diagram downward connector
L12_PYODERMAGANGRENOSUM

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L80-L99
Name in latin Pyoderma gangraenosum

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 134 80 54
Unadjusted prevalence (%) 0.04 0.04 0.03
Mean age at first event (years) 52.89 49.54 57.85

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_PYODERMAGANGRENOSUM – Pyoderma gangrenosum
GWS hits:

Survival analyses between endpoints

↥

Plot

before Pyoderma gangrenosum
after Pyoderma gangrenosum

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Pyoderma gangrenosum

↥